Real-word research on the effect and safety of gemcitabine combined with PD-1 inhibitors and recombinant human endostatin in refractory recurrent nasopharyngeal carcinoma.
Authors: Shuang Huang, Caineng Cao, Mengyun Qiang, Xiaozhong Chen, Le Wang
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e18016
Source:
Full article
Abstract
e18016